APO Research
Talk to an analyst

APO RESEARCH · REPORT

Streptococcus Pneumoniae Polysaccharide Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Streptococcus Pneumoniae Polysaccharide Vaccine Industry Research Report 2026

29 December 2025124 pages

Choose your research edition.

Industry ResearchStreptococcus Pneumoniae Polysaccharide Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Streptococcus Pneumoniae Polysaccharide Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Streptococcus Pneumoniae Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Streptococcus Pneumoniae Polysaccharide Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Streptococcus Pneumoniae Polysaccharide Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine include Yuxi Watson Biotechnology Co., Ltd, Merck & Co.,Inc, Pfizer Inc, Chengdu Institute of Biological Products Co., Ltd, Beijing Minhai Biotechnology Co., Ltd, Beijing Kexing Biological Products Co., Ltd, Serum Institute of India Pvt. Ltd, Sanofi Pasteur and Glaxosmithkline Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Streptococcus Pneumoniae Polysaccharide Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Streptococcus Pneumoniae Polysaccharide Vaccine Market by Company

Yuxi Watson Biotechnology Co., Ltd

Merck & Co.,Inc

Pfizer Inc

Chengdu Institute of Biological Products Co., Ltd

Beijing Minhai Biotechnology Co., Ltd

Beijing Kexing Biological Products Co., Ltd

Serum Institute of India Pvt. Ltd

Sanofi Pasteur

Glaxosmithkline Plc

China National Biotec Group

Astellas Pharma Inc

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Type

Single Dose Vial

Pre-Filled Syringe

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Application

Hospital

Clinic

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Streptococcus Pneumoniae Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Streptococcus Pneumoniae Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Streptococcus Pneumoniae Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Streptococcus Pneumoniae Polysaccharide Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Streptococcus Pneumoniae Polysaccharide Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Streptococcus Pneumoniae Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Streptococcus Pneumoniae Polysaccharide Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Streptococcus Pneumoniae Polysaccharide Vaccine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Streptococcus Pneumoniae Polysaccharide Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine, Product Type & Application Table 14. Global Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Streptococcus Pneumoniae Polysaccharide Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Yuxi Watson Biotechnology Co., Ltd Company Information Table 19. Yuxi Watson Biotechnology Co., Ltd Business Overview Table 20. Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 22. Yuxi Watson Biotechnology Co., Ltd Recent Developments Table 23. Merck & Co.,Inc Company Information Table 24. Merck & Co.,Inc Business Overview Table 25. Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 27. Merck & Co.,Inc Recent Developments Table 28. Pfizer Inc Company Information Table 29. Pfizer Inc Business Overview Table 30. Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 32. Pfizer Inc Recent Developments Table 33. Chengdu Institute of Biological Products Co., Ltd Company Information Table 34. Chengdu Institute of Biological Products Co., Ltd Business Overview Table 35. Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 37. Chengdu Institute of Biological Products Co., Ltd Recent Developments Table 38. Beijing Minhai Biotechnology Co., Ltd Company Information Table 39. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 40. Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 42. Beijing Minhai Biotechnology Co., Ltd Recent Developments Table 43. Beijing Kexing Biological Products Co., Ltd Company Information Table 44. Beijing Kexing Biological Products Co., Ltd Business Overview Table 45. Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 47. Beijing Kexing Biological Products Co., Ltd Recent Developments Table 48. Serum Institute of India Pvt. Ltd Company Information Table 49. Serum Institute of India Pvt. Ltd Business Overview Table 50. Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 52. Serum Institute of India Pvt. Ltd Recent Developments Table 53. Sanofi Pasteur Company Information Table 54. Sanofi Pasteur Business Overview Table 55. Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 57. Sanofi Pasteur Recent Developments Table 58. Glaxosmithkline Plc Company Information Table 59. Glaxosmithkline Plc Business Overview Table 60. Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 62. Glaxosmithkline Plc Recent Developments Table 63. China National Biotec Group Company Information Table 64. China National Biotec Group Business Overview Table 65. China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 67. China National Biotec Group Recent Developments Table 68. Astellas Pharma Inc Company Information Table 69. Astellas Pharma Inc Business Overview Table 70. Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 72. Astellas Pharma Inc Recent Developments Table 73. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 74. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2021-2026) & (K Units) Table 75. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Region (2021-2026) Table 76. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2027-2032) & (K Units) Table 77. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Region (2027-2032) Table 78. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 79. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region (2021-2026) Table 80. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 81. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region (2027-2032) Table 82. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 84. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 85. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 87. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 89. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 90. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 91. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 92. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 94. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 95. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 96. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 97. South America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 99. South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 100. South America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 101. South America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 102. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 104. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 105. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 106. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 107. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 108. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 109. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2021-2026) Table 110. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2027-2032) Table 111. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 112. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 113. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type (2021-2026) Table 114. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type (2027-2032) Table 115. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2021-2026) & (US$/Unit) Table 116. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2027-2032) & (US$/Unit) Table 117. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 118. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 119. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2021-2026) Table 120. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2027-2032) Table 121. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 122. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 123. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application (2021-2026) Table 124. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application (2027-2032) Table 125. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2021-2026) & (US$/Unit) Table 126. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2027-2032) & (US$/Unit) Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Streptococcus Pneumoniae Polysaccharide Vaccine Distributors List Table 130. Streptococcus Pneumoniae Polysaccharide Vaccine Customers List Table 131. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Trends Table 132. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Drivers Table 133. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Restraints Table 134. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Streptococcus Pneumoniae Polysaccharide Vaccine Product Image Figure 5. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (2021-2032) & (K Units) Figure 8. Global Streptococcus Pneumoniae Polysaccharide Vaccine Average Price (US$/Unit) & (2021-2032) Figure 9. Single Dose Vial Product Image Figure 10. Pre-Filled Syringe Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Streptococcus Pneumoniae Polysaccharide Vaccine Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region in 2025 Figure 19. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region in 2025 Figure 20. North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country in 2025 Figure 21. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 22. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Country (2021-2032) Figure 23. United States Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country in 2025 Figure 26. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 27. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Country (2021-2032) Figure 28. Germany Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. France Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. U.K. Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Italy Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Netherlands Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country in 2025 Figure 34. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 35. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Country (2021-2032) Figure 36. China Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Japan Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. South Korea Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. India Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Australia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. China Taiwan Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Southeast Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country in 2025 Figure 45. South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 46. South America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Country (2021-2032) Figure 47. Mexico Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Brazil Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Argentina Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country in 2025 Figure 51. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 52. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Country (2021-2032) Figure 53. Turkey Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Saudi Arabia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. UAE Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2021-2032) Figure 57. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type (2021-2032) Figure 58. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price (US$/Unit) by Type (2021-2032) Figure 59. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2021-2032) Figure 60. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application (2021-2032) Figure 61. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price (US$/Unit) by Application (2021-2032) Figure 62. Streptococcus Pneumoniae Polysaccharide Vaccine Value Chain Figure 63. Streptococcus Pneumoniae Polysaccharide Vaccine Production Mode & Process Figure 64. Direct Comparison with Distribution Share Figure 65. Distributors Profiles Figure 66. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Single Dose Vial
  • Pre-Filled Syringe
Applications
  • Hospital
  • Clinic
Companies covered
  • Yuxi Watson Biotechnology Co., Ltd
  • Merck & Co.,Inc
  • Pfizer Inc
  • Chengdu Institute of Biological Products Co., Ltd
  • Beijing Minhai Biotechnology Co., Ltd
  • Beijing Kexing Biological Products Co., Ltd
  • Serum Institute of India Pvt. Ltd
  • Sanofi Pasteur
  • Glaxosmithkline Plc
  • China National Biotec Group
  • Astellas Pharma Inc

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (2021-2032)
  5. 2.2.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Average Price (2021-2032)
  6. 2.3 Streptococcus Pneumoniae Polysaccharide Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Single Dose Vial
  9. 2.3.3 Pre-Filled Syringe
  10. 2.4 Streptococcus Pneumoniae Polysaccharide Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Streptococcus Pneumoniae Polysaccharide Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine, Established Date
  9. 3.9 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Yuxi Watson Biotechnology Co., Ltd
  2. 4.1.1 Yuxi Watson Biotechnology Co., Ltd Company Information
  3. 4.1.2 Yuxi Watson Biotechnology Co., Ltd Business Overview
  4. 4.1.3 Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  6. 4.1.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
  7. 4.2 Merck & Co.,Inc
  8. 4.2.1 Merck & Co.,Inc Company Information
  9. 4.2.2 Merck & Co.,Inc Business Overview
  10. 4.2.3 Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  12. 4.2.5 Merck & Co.,Inc Recent Developments
  13. 4.3 Pfizer Inc
  14. 4.3.1 Pfizer Inc Company Information
  15. 4.3.2 Pfizer Inc Business Overview
  16. 4.3.3 Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  18. 4.3.5 Pfizer Inc Recent Developments
  19. 4.4 Chengdu Institute of Biological Products Co., Ltd
  20. 4.4.1 Chengdu Institute of Biological Products Co., Ltd Company Information
  21. 4.4.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
  22. 4.4.3 Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  24. 4.4.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
  25. 4.5 Beijing Minhai Biotechnology Co., Ltd
  26. 4.5.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  27. 4.5.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  28. 4.5.3 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  30. 4.5.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  31. 4.6 Beijing Kexing Biological Products Co., Ltd
  32. 4.6.1 Beijing Kexing Biological Products Co., Ltd Company Information
  33. 4.6.2 Beijing Kexing Biological Products Co., Ltd Business Overview
  34. 4.6.3 Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  36. 4.6.5 Beijing Kexing Biological Products Co., Ltd Recent Developments
  37. 4.7 Serum Institute of India Pvt. Ltd
  38. 4.7.1 Serum Institute of India Pvt. Ltd Company Information
  39. 4.7.2 Serum Institute of India Pvt. Ltd Business Overview
  40. 4.7.3 Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  42. 4.7.5 Serum Institute of India Pvt. Ltd Recent Developments
  43. 4.8 Sanofi Pasteur
  44. 4.8.1 Sanofi Pasteur Company Information
  45. 4.8.2 Sanofi Pasteur Business Overview
  46. 4.8.3 Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  48. 4.8.5 Sanofi Pasteur Recent Developments
  49. 4.9 Glaxosmithkline Plc
  50. 4.9.1 Glaxosmithkline Plc Company Information
  51. 4.9.2 Glaxosmithkline Plc Business Overview
  52. 4.9.3 Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  54. 4.9.5 Glaxosmithkline Plc Recent Developments
  55. 4.10 China National Biotec Group
  56. 4.10.1 China National Biotec Group Company Information
  57. 4.10.2 China National Biotec Group Business Overview
  58. 4.10.3 China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  60. 4.10.5 China National Biotec Group Recent Developments
  61. 4.11 Astellas Pharma Inc
  62. 4.11.1 Astellas Pharma Inc Company Information
  63. 4.11.2 Astellas Pharma Inc Business Overview
  64. 4.11.3 Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  66. 4.11.5 Astellas Pharma Inc Recent Developments
5 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Scenario by Region
  1. 5.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Country
  15. 5.5.1 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2032)
  17. 5.5.3 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Country
  35. 5.7.1 South America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2032)
  37. 5.7.3 South America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Streptococcus Pneumoniae Polysaccharide Vaccine Value Chain Analysis
  2. 8.1.1 Streptococcus Pneumoniae Polysaccharide Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Streptococcus Pneumoniae Polysaccharide Vaccine Production Mode & Process
  5. 8.2 Streptococcus Pneumoniae Polysaccharide Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Streptococcus Pneumoniae Polysaccharide Vaccine Distributors
  8. 8.2.3 Streptococcus Pneumoniae Polysaccharide Vaccine Customers
9 Global Streptococcus Pneumoniae Polysaccharide Vaccine Analyzing Market Dynamics
  1. 9.1 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Trends
  2. 9.2 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Drivers
  3. 9.3 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 9.4 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst